Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.

Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, Lantieri O, Launoy G, Guittet L.

Int J Cancer. 2014 Sep 5. doi: 10.1002/ijc.29187. [Epub ahead of print]

PMID:
25195670
[PubMed - as supplied by publisher]
2.

The psychological impact of participating in colorectal cancer screening by faecal immuno-chemical testing--the Australian experience.

Bobridge A, Bampton P, Cole S, Lewis H, Young G.

Br J Cancer. 2014 Aug 26;111(5):970-5. doi: 10.1038/bjc.2014.371. Epub 2014 Jul 1.

PMID:
24983363
[PubMed - indexed for MEDLINE]
3.

Attendance and yield over three rounds of population-based fecal immunochemical test screening.

Kapidzic A, Grobbee EJ, Hol L, van Roon AH, van Vuuren AJ, Spijker W, Izelaar K, van Ballegooijen M, Kuipers EJ, van Leerdam ME.

Am J Gastroenterol. 2014 Aug;109(8):1257-64. doi: 10.1038/ajg.2014.168. Epub 2014 Jul 1.

PMID:
24980879
[PubMed - indexed for MEDLINE]
4.

Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.

Auge JM, Pellise M, Escudero JM, Hernandez C, Andreu M, Grau J, Buron A, López-Cerón M, Bessa X, Serradesanferm A, Piracés M, Macià F, Guayta R, Filella X, Molina R, Jimenez W, Castells A; PROCOLON Group.

Gastroenterology. 2014 Sep;147(3):628-636.e1. doi: 10.1053/j.gastro.2014.06.008. Epub 2014 Jun 14.

PMID:
24937264
[PubMed - indexed for MEDLINE]
5.

KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.

Battaglia P, Baritono E, Remo A, Vendraminelli R, Conti A.

Tumori. 2014 Mar-Apr;100(2):122-7. doi: 10.1700/1491.16391.

PMID:
24852854
[PubMed - indexed for MEDLINE]
6.

To foster screening, new colon cancer tests emphasize convenience.

Willyard C.

Nat Med. 2014 Apr;20(4):322-3. doi: 10.1038/nm0414-322. No abstract available.

PMID:
24710365
[PubMed - indexed for MEDLINE]
7.

Multitarget stool DNA testing for colorectal-cancer screening.

Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM.

N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.

PMID:
24645800
[PubMed - indexed for MEDLINE]
Free Article
8.

Colorectal cancer screening among government servants in Brunei Darussalam.

Chong VH, Bakar S, Sia R, Lee J, Kassim N, Rajak L, Abdullah MS, Chong CF.

Asian Pac J Cancer Prev. 2013;14(12):7657-61.

PMID:
24460349
[PubMed - indexed for MEDLINE]
Free Article
9.

Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.

Koga Y, Yamazaki N, Takizawa S, Kawauchi J, Nomura O, Yamamoto S, Saito N, Kakugawa Y, Otake Y, Matsumoto M, Matsumura Y.

Anticancer Res. 2014 Jan;34(1):169-76.

PMID:
24403458
[PubMed - indexed for MEDLINE]
10.

Analytical and clinical performance of Kroma iT, a compact fully-automated immunochemistry analyzer for fecal occult hemoglobin.

Auge JM, Rodriguez C, Pellise M, Bernal A, Grau J, Castells A, Filella X, Molina R.

Anticancer Res. 2013 Dec;33(12):5633-7.

PMID:
24324109
[PubMed - indexed for MEDLINE]
11.

[Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].

Huang YQ, Zhang MW, Shen YZ, Ma HQ, Cai SR, Zhang SZ, Zheng S.

Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Aug;47(8):747-51. Chinese.

PMID:
24246083
[PubMed - indexed for MEDLINE]
12.

Screening for colorectal cancer in individuals at average risk: current methods and emerging issues.

Lieberman D.

JAMA Intern Med. 2014 Jan;174(1):10-1. doi: 10.1001/jamainternmed.2013.11499. No abstract available.

PMID:
24145734
[PubMed - indexed for MEDLINE]
13.

Nano-architectural alterations in mucus layer fecal colonocytes in field carcinogenesis: potential for screening.

Roy HK, Damania DP, DelaCruz M, Kunte DP, Subramanian H, Crawford SE, Tiwari AK, Wali RK, Backman V.

Cancer Prev Res (Phila). 2013 Oct;6(10):1111-9. doi: 10.1158/1940-6207.CAPR-13-0138. Epub 2013 Aug 27.

PMID:
23983085
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Strategies for expanding colorectal cancer screening at community health centers.

Sarfaty M, Doroshenk M, Hotz J, Brooks D, Hayashi S, Davis TC, Joseph D, Stevens D, Weaver DL, Potter MB, Wender R.

CA Cancer J Clin. 2013 Jul-Aug;63(4):221-31. doi: 10.3322/caac.21191.

PMID:
23818334
[PubMed - indexed for MEDLINE]
15.

Fecal immunochemical test accuracy in familial risk colorectal cancer screening.

Castro I, Cubiella J, Rivera C, González-Mao C, Vega P, Soto S, Hernandez V, Iglesias F, Teresa Alves M, Bujanda L, Fernández-Seara J.

Int J Cancer. 2014 Jan 15;134(2):367-75. doi: 10.1002/ijc.28353. Epub 2013 Sep 23.

PMID:
23818169
[PubMed - indexed for MEDLINE]
16.

Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.

Brenner H, Tao S.

Eur J Cancer. 2013 Sep;49(14):3049-54. doi: 10.1016/j.ejca.2013.04.023. Epub 2013 May 22.

PMID:
23706981
[PubMed - indexed for MEDLINE]
17.

New strategies for colorectal cancer screening.

Di Lena M, Travaglio E, Altomare DF.

World J Gastroenterol. 2013 Mar 28;19(12):1855-60. doi: 10.3748/wjg.v19.i12.1855.

PMID:
23569331
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Faecal haemoglobin concentration is related to severity of colorectal neoplasia.

Digby J, Fraser CG, Carey FA, McDonald PJ, Strachan JA, Diament RH, Balsitis M, Steele RJ.

J Clin Pathol. 2013 May;66(5):415-9. doi: 10.1136/jclinpath-2013-201445. Epub 2013 Feb 15.

PMID:
23418340
[PubMed - indexed for MEDLINE]
19.

Screening and surveillance for colorectal cancer: state of the art.

Kahi CJ, Anderson JC, Rex DK.

Gastrointest Endosc. 2013 Mar;77(3):335-50. doi: 10.1016/j.gie.2013.01.002. Review. No abstract available.

PMID:
23410695
[PubMed - indexed for MEDLINE]
20.

The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies?

van Dam L, Kuipers EJ, Steyerberg EW, van Leerdam ME, de Beaufort ID.

Lancet Oncol. 2013 Jan;14(1):e38-46. doi: 10.1016/S1470-2045(12)70455-2.

PMID:
23276372
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk